44 results
424B2
SAVA
Cassava Sciences Inc
3 Jan 24
Prospectus for primary offering
4:22pm
, simufilam, is a proprietary small molecule (oral) drug. Simufilam targets an altered form of a protein called filamin A (FLNA) in the Alzheimer’s brain
8-K
EX-99.1
quzpevmo2 8g
26 Apr 22
Regulation FD Disclosure
3:45pm
8-K
EX-99.1
n0jus 59d6yknh2
3 Aug 21
Regulation FD Disclosure
4:36pm
8-K
EX-99.1
brezpe3 udrq0ja
21 Apr 21
Cassava Sciences Reports First Quarter 2021 Financial Results and Announces Guidance on Clinical Data Release
8:45am